ReviewNeuropsychiatric disease and treatment2024

New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists.

Aineng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.